Strata Critical Medical, Inc. (SRTA): auditor change — Blade Air Mobility dismisses Marcum, appoints Deloitte as auditor for FY2024

Strata Critical Medical, Inc.

Audit committee dismissed Marcum LLP on March 19, 2024; no disagreements on accounting or auditing matters.
Marcum's audit reports for FY2023 were unqualified; material weakness in internal controls was previously disclosed.
Deloitte & Touche LLP appointed on March 20, 2024 as independent auditor for fiscal year ending Dec 31, 2024.
Marcum provided a letter (Exhibit 16.1) agreeing with the Company's statements in this report.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Strata Critical Medical, Inc. engaged Deloitte & Touche LLP as its auditor.

Action: engagement
Auditor: Deloitte & Touche LLP

Exact text from the filing

On March 20, 2024, the Audit Committee approved the appointment of Deloitte & Touche LLP ("Deloitte") as its new independent registered public accounting firm for the fiscal year ending December 31, 2024, subject to execution of an engagement letter.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Strata Critical Medical, Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP
Successor: Deloitte & Touche LLP

Exact text from the filing

On March 19, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Blade Air Mobility, Inc., a Delaware corporation (the "Company") dismissed Marcum LLP ("Marcum") as the Company's independent registered public accounting firm.

View on SEC.gov

46 auditor changes filed in the last 30 days. Browse all auditor changes →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001779128-24-000047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.